Stock News

Bristol-Myers Squibb Company -- Moody's announces completion of a periodic review of ratings of Bristol-Myers Squibb Company
NASDAQ: CELG Investor Notice: Update in Lawsuit against Celgene Corporation announced by Shareholders Foundation
Bristol-Myers business development head Biondi departs
Bristol-Myers Jumps After Celgene-Acquired Cancer Treatment Shows Promise
Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal
Bristol-Myers Squibb Company -- Moody's upgrades Celgene to A3
Here is the 17th Most Popular Stock Among 752 Hedge Funds

As seen on...